Published in Drug Week, July 28th, 2006
"Hylenex is the first and only FDA (U.S. Food & Drug Administration) - approved recombinant human hyaluronidase drug product, and we are proud to make it available to healthcare providers as a way to simplify the delivery of medications and fluids and, ultimately, provide a more comfortable patient experience," said Jonathan Lim, MD, president and CEO of Halozyme.
The companies will focus predominantly on making the product available to hospices and palliative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week